Lecithin nanoparticles show promise as vaccine adjuvant
Date: 20.1.2010
A team at Oregon State University has developed a new adjuvant, a substance that can increased the **immune response** when used in combination with a vaccine, based on **lecithin nanoparticles**. Currently only one adjuvant, **aluminium hydroxide** (alum), is approved for human use in the US because of safety concerns and is comparatively weak as well as only working with certain diseases.
More on "Nano":[ http://www.nano.org.uk/nanomednet/index.php?option=com_content&task=view&id=378&Itemid=1]
